Treatment
Medication clinical trials
We’re tracking 7,435 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07270263Recruiting
Lower-dose blood thinners for people with blood cancers
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT07270718Recruiting
Beetroot powder for blood pressure in men with hypertension
This trial tests whether taking 20 grams of beetroot powder daily can help lower blood pressure and improve blood flow in men who already have high blood pressure under control with medication. Beetroot is rich in nitrates, which may relax blood vessels.
MoscowAges 18–60 - NCT07270757Recruiting
Pre-ablation exercise program for atrial fibrillation
This study tests whether a short exercise and education program before a first-time ablation for atrial fibrillation improves your recovery and heart fitness. It's for people with mild or no heart failure symptoms and a well-pumping heart.
Nanjing, Please SelectAges 18–70 - NCT07271836Recruiting
Keeping long-acting contraception through education
This trial tests if education can help women keep using their long-acting birth control methods like copper-T IUDs or Jadelle implants instead of removing them early. It might help you stay on effective contraception.
Islamabad, IslamabadAges 18–49 - NCT07273344Recruiting
How the immune system responds to sepsis
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
Nijmegen, GelderlandAges 18 years+ - NCT07273422Recruiting
Smart insoles study for healthy adults
This trial is testing a new smart insole that tracks your body's signals while you walk. You'll visit the study center once a week for 4 weeks to test the insoles.
Williamsport, PennsylvaniaAges 18–90 - NCT07273721RecruitingPhase 2
Testing BT200 in type 2B von Willebrand disease
This trial tests a new medicine called BT200 (rondaptivon pegol) to see if it can safely help people with type 2B von Willebrand disease who have low platelets and recent bleeding problems.
Vienna, State of ViennaAges 18 years+ - NCT07273812Recruiting
AI phone app to help with chemotherapy side effects in breast cancer
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
BaghdadAges 18 years+ - NCT07274527Recruiting
Amnioinfusion for babies exposed to thick meconium during labor
This trial tests whether adding fluid into the womb (amnioinfusion) during labor can protect a baby's lungs and health after being exposed to thick meconium (baby's first poop). It may help reduce breathing problems and improve long-term outcomes.
Milwaukee, WisconsinAges 18 years+ - NCT07275372Recruiting
Virtual humans help nursing students learn cognitive tests
This trial tests if virtual humans can help nursing students learn to assess cognitive function using the SPMSQ test. It may improve how future nurses evaluate memory and thinking.
Taipei, TaiwanAges 18–65 - NCT07277439RecruitingPhase 2
Immunotherapy and chemoradiation before surgery for stomach cancer
This study tests combining an immunotherapy drug (PD-1 inhibitor) and a medication to boost your immune system (thymalfasin) with standard chemotherapy and radiation before surgery for stage III cancer where the stomach meets the esophagus. The goal is to see if this approach can shrink the tumor and improve outcomes.
Nanjing, JiangsuAges 18–75 - NCT07277608Recruiting
Study on sleep apnea patients and their health over time
This study looks at patients with suspected or confirmed obstructive sleep apnea (a condition where breathing stops and starts during sleep) to understand the condition better. Researchers will follow patients for at least one year to learn more about the underlying causes and how it affects health.
Beijing, Beijing MunicipalityAges Any age - NCT07278609Recruiting
Safer medication use for older adults with rheumatic conditions
This study tests a program to help doctors choose safer medications for people aged 60 and older who have arthritis or other rheumatic conditions. It aims to reduce the use of potentially harmful drugs and improve overall medication safety.
Montreal, QuebecAges 60 years+ - NCT07278856RecruitingPhase 1
Ruxolitinib plus CHOP for untreated T-follicular helper cell lymphoma
This trial tests adding an oral targeted drug called ruxolitinib to the standard CHOP chemotherapy for people newly diagnosed with a rare type of lymphoma. The goal is to see if this combination is safe and works well.
Duarte, CaliforniaAges 18 years+ - NCT07278960Recruiting
Study on improving care for children born through IVF
This study looks at how to better manage the health of children up to 3 years old who were conceived with help from fertility treatments like IVF or ICSI. Researchers want to see if new care plans can improve their development and health outcomes.
AlmatyAges birth–3 years - NCT07278999Recruiting
Light therapy and clobetasol for oral lichen planus
This trial tests two light-based treatments (photobiomodulation and photodynamic therapy) and a steroid cream (clobetasol) for painful oral lichen planus. The goal is to see which treatment works best to reduce mouth sores and discomfort.
Zabrze, Silesian VoivodeshipAges 20–70 - NCT07279623Recruiting
Nasal stimulation device for migraine prevention
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
StockholmAges 18–65 - NCT07280390Recruiting
Microplastics in people with cirrhosis
This trial checks whether tiny plastic particles (microplastics) are present in the liver and body of people with cirrhosis who are having planned surgery or a liver transplant. It aims to understand if microplastics might make liver disease worse.
Chandigarh, ChandigarhAges 18–70 - NCT07281846Recruiting
TIPS with or without BCAA for cirrhosis and muscle wasting
This trial tests whether adding branched-chain amino acids (BCAA) to the standard TIPS procedure helps people with cirrhosis and muscle wasting. It aims to see if BCAA can improve outcomes after TIPS.
WuhanAges 18–80 - NCT07282262RecruitingPhase 2
Ivosidenib for advanced bile duct cancer with IDH1 mutation
This trial tests the drug Ivosidenib for people with advanced bile duct cancer that has a specific genetic change called an IDH1 mutation. It may be an option if you haven't had chemotherapy yet or if your cancer returned more than 6 months after surgery.
BeijingAges 18–80 - NCT07282756Recruiting
Lovastatin gel for gum disease treatment
This study tests whether a lovastatin gel applied to the gums (after a deep cleaning) helps treat gum disease better than cleaning alone. Participants must not have had previous gum treatment or antibiotics recently, and can be a smoker or non-smoker.
Bielsko-Biala, Silesian VoivodeshipAges 18–59 - NCT07283094RecruitingPhase 1
FHD-286 with decitabine and venetoclax for AML
This early-phase trial tests a new study drug called FHD-286 combined with two standard AML medicines (decitabine and venetoclax). It is for people with a high-risk type of AML that is either newly diagnosed (and you cannot have strong chemotherapy) or has come back after one prior treatment.
The Bronx, New YorkAges 18 years+ - NCT07284550Recruiting
Smartphone screening for aortic valve stenosis
This study tests if a smartphone app can detect aortic valve stenosis (a heart valve condition) by recording heart sounds. If successful, it could offer a simple, non-invasive way to screen for this condition without a doctor's visit.
InnsbruckAges 18 years+ - NCT07285083Recruiting
Pain relief after abdominal surgery: comparing two numbing medicines
This study compares two numbing medicines (bupivacaine alone vs. bupivacaine plus dexmedetomidine) to see which provides better pain relief after abdominal surgery. If you are having a planned abdominal operation, this trial may help improve your recovery comfort.
Rahim Yar Khan, Punjab ProvinceAges 21–45
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,435 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.